SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing heavy selling pressure as investors weigh significant AI infrastructure spending and mounting debt against long-term growth prospects in the cloud sector. While sentiment remains fractured, the community is actively debating whether current price levels represent a high-risk "falling knife" or a contrarian buying opportunity for long-term holders.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is facing intense volatility as the market digests significant margin calls and forced liquidations among leveraged retail accounts in South Korea. While bulls are discussing potential support levels and anticipating a relief rally fueled by strong memory chip demand, bears are highlighting the risks of decay and the potential for further downside given the country's economic exposure.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI continues to be a focal point for investors due to its highly concentrated options positioning, elevated short interest, and ongoing merger activity with LivePerson. While some community members remain skeptical of the stock's fundamental direction and recent price action, bulls are actively focused on technical breakout levels and the potential for a gamma-driven short squeeze if the stock maintains momentum.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing extreme volatility as traders pivot between potential upside from new semiconductor IPOs like SK Hynix and heightened market anxiety fueled by geopolitical conflict in the Middle East. The community remains deeply divided, with bulls aggressively buying dips in anticipation of an AI-driven sector recovery, while bears warn of significant decay risks, potential reverse splits, and broader macroeconomic instability.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is surging as geopolitical instability returns to the forefront, driven by renewed U.S. strikes on Iranian infrastructure and threats to the Strait of Hormuz. Community sentiment is deeply divided, with many traders debating whether these escalations represent a structural shift in energy supply or another cycle of political brinkmanship that will lead to a rapid price reversal.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The market is experiencing significant volatility and downward pressure as investors rotate out of tech and speculative AI plays amid rising geopolitical tensions in the Middle East and a potential interest rate hike signal from the Federal Reserve. Community sentiment remains polarized, with many traders closely monitoring CPI data and corporate earnings for a catalyst to break the current range-bound price action.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is currently trending due to positive Phase 2a clinical data for bempikibart in treating alopecia areata, which has sparked significant momentum and analyst upgrades. While bulls are celebrating the clinical breakthrough and recent financing, the community is actively debating the potential for future dilution versus the possibility of long-term value creation.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is generating buzz as it launches its first restaurant in Mexico, a strategic move aimed at international expansion that has investors debating whether the brand can successfully scale its footprint globally. While some traders are bullish on the international growth narrative and recent stock activity, the community remains divided, with vocal critics pointing to concerns over portion sizes and quality consistency impacting domestic sentiment.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility driven by intense institutional options activity and sensitivity to South Korean semiconductor market movements. The community remains divided between long-term bulls betting on sustained AI memory demand and bears concerned about overvaluation and potential sector-wide supply cycles.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is currently experiencing intense volatility as investors weigh the highly anticipated U.S. ADR listing of SK Hynix against broader concerns regarding a semiconductor sector cooldown. While the community remains divided between those viewing the pullback as a buying opportunity based on long-term AI infrastructure demand and those fearing a deeper cyclical downturn, active discussions are centered on institutional oversubscription levels for the upcoming IPO and extreme price swings within the Korean equity markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO (vosoritide) for Children With Achondroplasia

U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO (vosoritide) for Children With Achondroplasia U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO (vosoritide) for...

BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth

BBIO builds on Attruby's launch as rising rare disease diagnoses and late-stage pipeline candidates set up multiple potential U.S. launches.

Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead

BridgeBio Pharma's Attruby sales are surging, but can growth keep justifying its premium valuation amid execution risks and rising costs?

BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts

BBIO's outlook hinges on Attruby growth, upcoming drug launch catalysts and execution as it seeks to diversify beyond its lone marketed therapy.

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?

ABCELLERA BIOLG (ABCL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

BioMarin Announces New Three-Year VOXZOGO (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026

BioMarin Announces New Three-Year VOXZOGO (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026 BioMarin Announces New Three-Year VOXZOGO (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026 PR Newswire SAN RAFAEL, Calif., June 16, 2026 Data from an...

Biomarin Pharmaceutical (BMRN): Most Undervalued Stocks to Buy and Hold for 2 Years

Biomarin Pharmaceutical (BMRN): Most Undervalued Stocks to Buy and Hold for 2 Years...

BioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?

BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BioMarin Pharmaceutical Inc. (BMRN) A Stock that Could 10x by 2030 on Pipeline Development

BioMarin Pharmaceutical Inc. (BMRN) A Stock that Could 10x by 2030 on Pipeline Development...

BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$59.20
Prev Close	$59.12
Open	$59.12
Dividend Yield	0.00%
50-Day Moving Average	$55.31
Beta	0.64
Avg. Volume	2.21M
PE Ratio	43.14

52-Week High	$66.28
52-Week Low	$49.26
Market Capitalization	$11.43B
EPS (Annual)	$1.80
Price to Book	1.84
Revenue Per Employee	$1.01M

Feed

News

Sentiment

Earnings

Fundamentals

Info

BMRNBiomarin Pharmaceutical Inc. - Registered Shares

Latest BMRN News